Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2).

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMC 1134712)

Published in Biochem J on January 15, 2005

Authors

Tavan Janvilisri1, Sanjay Shahi, Henrietta Venter, Lekshmy Balakrishnan, Hendrik W van Veen

Author Affiliations

1: Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK.

Articles citing this

Recent Advances in the Application of Solution NMR Spectroscopy to Multi-Span Integral Membrane Proteins. Prog Nucl Magn Reson Spectrosc (2009) 1.57

Human ABCG2: structure, function, and its role in multidrug resistance. Int J Biochem Mol Biol (2011) 1.21

ABCG transporters: structure, substrate specificities and physiological roles : a brief overview. J Bioenerg Biomembr (2007) 1.09

The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2). Br J Pharmacol (2007) 1.03

Gene variants associated with ischemic stroke: the cardiovascular health study. Stroke (2008) 0.95

The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding. Protein Sci (2006) 0.94

Macrolide resistance mediated by a Bifidobacterium breve membrane protein. Antimicrob Agents Chemother (2005) 0.89

Role of breast cancer resistance protein in the adaptive response to cholestasis. Drug Metab Dispos (2010) 0.87

Isotope labeling for solution and solid-state NMR spectroscopy of membrane proteins. Adv Exp Med Biol (2012) 0.87

Clinical application of transcriptional activators of bile salt transporters. Mol Aspects Med (2013) 0.87

Excretion of biliary compounds during intrauterine life. World J Gastroenterol (2009) 0.85

Regulation of the function of the human ABCG2 multidrug transporter by cholesterol and bile acids: effects of mutations in potential substrate and steroid binding sites. Drug Metab Dispos (2014) 0.81

Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice. J Lipid Res (2014) 0.80

High doses of ursodeoxycholic acid up-regulate the expression of placental breast cancer resistance protein in patients affected by intrahepatic cholestasis of pregnancy. PLoS One (2013) 0.80

Bone marrow mesenchymal stem cells provide an antibiotic-protective niche for persistent viable Mycobacterium tuberculosis that survive antibiotic treatment. Am J Pathol (2014) 0.78

Hepatobiliary disposition of 3alpha,6alpha,7alpha,12alpha-tetrahydroxy-cholanoyl taurine: a substrate for multiple canalicular transporters. Drug Metab Dispos (2010) 0.77

Identification of residues in ABCG2 affecting protein trafficking and drug transport, using co-evolutionary analysis of ABCG sequences. Biosci Rep (2015) 0.76

Development of conformation independent computational models for the early recognition of breast cancer resistance protein substrates. Biomed Res Int (2013) 0.75

Maternal bile acid transporter deficiency promotes neonatal demise. Nat Commun (2015) 0.75

Articles cited by this

Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl Environ Microbiol (1996) 7.12

A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A (1998) 6.47

Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res (2001) 4.05

Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest (2002) 3.85

The brown protein of Drosophila melanogaster is similar to the white protein and to components of active transport complexes. Mol Cell Biol (1988) 2.98

The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci U S A (2002) 2.79

ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci U S A (2000) 2.77

The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res (2002) 2.75

Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res (1999) 2.70

Pheophorbide a is a specific probe for ABCG2 function and inhibition. Cancer Res (2004) 1.82

Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. Cancer Res (2001) 1.81

Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2. J Biol Chem (2004) 1.76

Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res (2003) 1.62

Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol Pharmacol (2004) 1.50

Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Res (2002) 1.50

Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res (2004) 1.46

The purified and functionally reconstituted multidrug transporter LmrA of Lactococcus lactis mediates the transbilayer movement of specific fluorescent phospholipids. Biochemistry (1999) 1.45

Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. Biochem Biophys Res Commun (2001) 1.33

A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for Doxorubicin resistance. Cancer Res (2002) 1.30

Breast cancer resistance protein exports sulfated estrogens but not free estrogens. Mol Pharmacol (2003) 1.26

ABCG2 transports sulfated conjugates of steroids and xenobiotics. J Biol Chem (2003) 1.24

Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis. J Biol Chem (2003) 1.17

The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res (2003) 1.17

Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2. Biochim Biophys Acta (2002) 1.14

In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin. Eur J Pharm Sci (2000) 1.01

A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport. Biochem J (2003) 1.00

Interaction of the breast cancer resistance protein with plant polyphenols. Biochem Biophys Res Commun (2004) 0.99

Functional characterization of human breast cancer resistance protein (BCRP, ABCG2) expressed in the oocytes of Xenopus laevis. Mol Pharmacol (2003) 0.96

Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampin. J Pharmacol Exp Ther (2003) 0.96

Human MDR1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not of retinoic acid or benzo(a)pyrene. Arch Biochem Biophys (1998) 0.87

NtWBC1, an ABC transporter gene specifically expressed in tobacco reproductive organs. J Exp Bot (2004) 0.83

Articles by these authors

The ATP binding cassette multidrug transporter LmrA and lipid transporter MsbA have overlapping substrate specificities. J Biol Chem (2003) 1.54

Mass spectrometry of membrane transporters reveals subunit stoichiometry and interactions. Nat Methods (2009) 1.51

Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1. Trends Biochem Sci (2009) 1.46

Molecular basis of multidrug transport by ABC transporters. Biochim Biophys Acta (2008) 1.46

Drug-lipid A interactions on the Escherichia coli ABC transporter MsbA. J Bacteriol (2005) 1.25

An ABC transporter with a secondary-active multidrug translocator domain. Nature (2003) 1.21

Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis. J Biol Chem (2003) 1.17

MacB ABC transporter is a dimer whose ATPase activity and macrolide-binding capacity are regulated by the membrane fusion protein MacA. J Biol Chem (2008) 1.16

Plasmodium falciparum expresses a multidrug resistance-associated protein. Biochem Biophys Res Commun (2004) 1.11

Multidrug transport by the ABC transporter Sav1866 from Staphylococcus aureus. Biochemistry (2008) 1.11

On the energy-dependence of Hoechst 33342 transport by the ABC transporter LmrA. Biochem Pharmacol (2007) 1.10

ABCG transporters: structure, substrate specificities and physiological roles : a brief overview. J Bioenerg Biomembr (2007) 1.09

A flexible cation binding site in the multidrug major facilitator superfamily transporter LmrP is associated with variable proton coupling. FASEB J (2010) 1.02

Functional role of transmembrane helix 6 in drug binding and transport by the ABC transporter MsbA. Biochemistry (2008) 1.01

Reversible transport by the ATP-binding cassette multidrug export pump LmrA: ATP synthesis at the expense of downhill ethidium uptake. J Biol Chem (2003) 0.99

Interaction of the breast cancer resistance protein with plant polyphenols. Biochem Biophys Res Commun (2004) 0.99

A high-throughput method for membrane protein solubility screening: the ultracentrifugation dispersity sedimentation assay. Protein Sci (2007) 0.98

New light on multidrug binding by an ATP-binding-cassette transporter. Trends Pharmacol Sci (2006) 0.95

A critical role of a carboxylate in proton conduction by the ATP-binding cassette multidrug transporter LmrA. FASEB J (2005) 0.95

Dissection of the conformational cycle of the multidrug/lipidA ABC exporter MsbA. Proteins (2010) 0.94

Promiscuous partnering and independent activity of MexB, the multidrug transporter protein from Pseudomonas aeruginosa. Biochem J (2010) 0.94

ABC transporters and drug resistance in parasitic protozoa. Int J Antimicrob Agents (2003) 0.93

Substrate binding stabilizes a pre-translocation intermediate in the ATP-binding cassette transport protein MsbA. J Biol Chem (2013) 0.91

A functional steroid-binding element in an ATP-binding cassette multidrug transporter. Mol Pharmacol (2008) 0.89

The multidrug transporter LmrP protein mediates selective calcium efflux. J Biol Chem (2012) 0.88

Probing the molecular dynamics of the ABC multidrug transporter LmrA by deuterium solid-state nuclear magnetic resonance. Biochemistry (2007) 0.87

Structural biology: Last of the multidrug transporters. Nature (2010) 0.87

A multidrug ABC transporter with a taste for salt. PLoS One (2009) 0.87

Probing the ATP hydrolysis cycle of the ABC multidrug transporter LmrA by pulsed EPR spectroscopy. J Am Chem Soc (2012) 0.87

Purification and properties of the Escherichia coli nucleoside transporter NupG, a paradigm for a major facilitator transporter sub-family. Mol Membr Biol (2004) 0.87

The choreography of multidrug export. Biochem Soc Trans (2011) 0.86

Molecular disruption of the power stroke in the ATP-binding cassette transport protein MsbA. J Biol Chem (2013) 0.85

Two proton translocation pathways in a secondary active multidrug transporter. J Mol Microbiol Biotechnol (2007) 0.85

β-Lactam selectivity of multidrug transporters AcrB and AcrD resides in the proximal binding pocket. J Biol Chem (2014) 0.85

cGMP and glutathione-conjugate transport in human erythrocytes. Eur J Biochem (2003) 0.85

Metabolites of ginsenosides as novel BCRP inhibitors. Biochem Biophys Res Commun (2006) 0.84

The role of Trypanosoma brucei MRPA in melarsoprol susceptibility. Mol Biochem Parasitol (2005) 0.83

Tuning the drug efflux activity of an ABC transporter in vivo by in vitro selected DARPin binders. PLoS One (2012) 0.82

Basic residues R260 and K357 affect the conformational dynamics of the major facilitator superfamily multidrug transporter LmrP. PLoS One (2012) 0.82

Caught in the act: ATP hydrolysis of an ABC-multidrug transporter followed by real-time magic angle spinning NMR. FEBS Lett (2008) 0.80

A new dimer interface for an ABC transporter. Int J Antimicrob Agents (2003) 0.80

A new experimental approach to detect long-range conformational changes transmitted between the membrane and cytosolic domains of LmrA, a bacterial multidrug transporter. FEBS Lett (2002) 0.79

A Pilot Study on Screening of BRCA1 Mutations (185delAG, 1294del40) in Nepalese Breast Cancer Patients. Asian Pac J Cancer Prev (2016) 0.79

Mutations in MexB that affect the efflux of antibiotics with cytoplasmic targets. FEMS Microbiol Lett (2012) 0.79

Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump. Microbiologyopen (2014) 0.78

Modulation of p-glycoprotein and breast cancer resistance protein by some prescribed corticosteroids. Eur J Pharmacol (2006) 0.77

S-decyl-glutathione nonspecifically stimulates the ATPase activity of the nucleotide-binding domains of the human multidrug resistance-associated protein, MRP1 (ABCC1). Eur J Biochem (2002) 0.77

Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria. Curr Drug Targets (2016) 0.77

New structure model for the ATP-binding cassette multidrug transporter LmrA. Biochem Pharmacol (2007) 0.75

"The Art of Successful Publication" ECCO 13 workshop report. Eur J Cancer (2006) 0.75